ARMP

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Armata Pharmaceuticals Inc

NYSE MKT | ARMP

5.94

USD

$0.00

(

0.00%

)

At Close (As of Dec 4, 2025)

$218.08M

Market Cap

-

P/E Ratio

-1.66

EPS

$7.44

52 Week High

$0.90

52 Week Low

HEALTHCARE

Sector

ARMP Chart

Recent Chart
Price Action

ARMP Technicals

Tags:

ARMP Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$29M
Total Revenue $5.2M
Cost Of Revenue $34M
Costof Goods And Services Sold $34M
Operating Income -$42M
Selling General And Administrative $13M
Research And Development $34M
Operating Expenses $13M
Investment Income Net -
Net Interest Income -$10M
Interest Income $697K
Interest Expense $11M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$19M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$41M
Net Income -$19M

Revenue & Profitability

Earnings Performance

ARMP Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $86M
Total Current Assets $11M
Cash And Cash Equivalents At Carrying Value $9.3M
Cash And Short Term Investments $9.3M
Inventory -
Current Net Receivables $744K
Total Non Current Assets $75M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $10M
Intangible Assets Excluding Goodwill $10M
Goodwill $3.5M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.3M
Other Non Current Assets -
Total Liabilities $134M
Total Current Liabilities $48M
Current Accounts Payable $766K
Deferred Revenue -
Current Debt -
Short Term Debt $43M
Total Non Current Liabilities $86M
Capital Lease Obligations $32M
Long Term Debt $55M
Current Long Term Debt $39M
Long Term Debt Noncurrent -
Short Long Term Debt Total $127M
Other Current Liabilities $4.1M
Other Non Current Liabilities -
Total Shareholder Equity -$48M
Treasury Stock -
Retained Earnings -$328M
Common Stock $362K
Common Stock Shares Outstanding $36M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$38M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.3M
Capital Expenditures $1.9M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$1.9M
Cashflow From Financing $35M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$19M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$29M
Total Revenue $5.2M
Cost Of Revenue $34M
Costof Goods And Services Sold $34M
Operating Income -$42M
Selling General And Administrative $13M
Research And Development $34M
Operating Expenses $13M
Investment Income Net -
Net Interest Income -$10M
Interest Income $697K
Interest Expense $11M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$19M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$41M
Net Income -$19M

ARMP News

ARMP Profile

Armata Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Armata Pharmaceuticals Inc. is a clinical-stage biotechnology firm headquartered in Marina del Rey, California, dedicated to pioneering bacteriophage-based therapies to combat the growing challenge of antibiotic-resistant infections. Leveraging cutting-edge technologies and extensive research capabilities, the company develops targeted treatment solutions that are essential in the management of infectious diseases. With a strong pipeline of innovative therapeutic candidates and strategic partnerships, Armata is strategically positioned as a leader in the urgent fight against antimicrobial resistance, aiming to improve patient outcomes and redefine standards of care in the global healthcare landscape.

LPTX
+368.57%
$2.05
PAVS
-7.35%
$0.03
KALA
+4.21%
$0.96
NVDA
+2.11%
$183.38
ASST
-6.99%
$0.97
PLUG
0.00%
$2.23
PMCB
+54.21%
$1.21
INTC
-7.44%
$40.50
ONDS
+3.02%
$9.19
QCLS
+48.17%
$6.92
TNFA
+48.17%
$6.92
KITT
-25.00%
$1.17
IPG
-1.95%
$24.57
RR
+8.76%
$4.59
RGTI
+15.43%
$30.06
TSLA
+1.74%
$454.53
AXDX
-61.36%
$0.03
ACHR
+7.18%
$8.95
IXHL
+7.13%
$0.47
VHAI
+100.00%
$0.00
BYND
-0.80%
$1.24
INHD
+1.01%
$0.13
SOFI
+1.82%
$29.60
NIO
+4.59%
$5.01
BITF
-0.32%
$3.10
AAL
-1.51%
$14.34
QBTS
+14.55%
$28.73
BBD
+1.39%
$3.63
NFLX
-0.71%
$103.22
ADAP
-15.14%
$0.05
DNN
+5.18%
$2.84
VALE
+1.95%
$13.56
BMNR
+7.90%
$36.32
F
+0.38%
$13.14
AMZN
-1.40%
$229.11
AAPL
-1.21%
$280.70
SOND
-23.45%
$0.12
SMR
+13.45%
$22.85
BMNU
+15.34%
$9.32
RMBL
+60.50%
$3.21
IONZ
-25.48%
$3.10
LNW
-3.71%
$86.22
BAC
+0.12%
$54.16
WBD
-0.12%
$24.54
ADD
-25.47%
$0.05
RIVN
+3.02%
$18.06
IREN
+5.66%
$46.45
KVUE
+0.11%
$16.99
PMI
+82.67%
$3.69
IRBT
-10.61%
$3.03
SRM
+53.27%
$10.30
PFE
+0.50%
$25.70
IONQ
+12.55%
$54.76
CLSK
+3.72%
$15.03
TWOH
+9.09%
$0.00
PLTD
-1.04%
$6.66
BTBT
+2.14%
$2.38
HPE
+2.87%
$22.90
MARA
-0.24%
$12.44
T
+0.27%
$25.39
GOOGL
-0.62%
$317.62
GRAB
+0.56%
$5.30
SNAP
+1.30%
$7.76
CIFR
+6.44%
$19.83
META
+3.42%
$661.53
SOUN
+8.65%
$12.80
CRWV
+8.05%
$85.75
PFSA
-4.57%
$0.18
WULF
+4.64%
$15.10
ITUB
+1.89%
$8.07
PLTR
+1.04%
$177.92
QUBT
+12.51%
$13.58
WLGS
-5.57%
$0.04
EOSE
+15.05%
$15.59
BURU
+7.45%
$0.24
VZ
+1.45%
$41.26
MTSR
-0.35%
$70.50
RKLB
+10.39%
$49.37
STAI
+32.35%
$0.30
PLRZ
+104.51%
$14.50
HIMS
+7.95%
$40.02
ASTS
+18.24%
$72.65
AMD
-0.74%
$215.98
WMT
+0.37%
$114.84
MRVL
-2.00%
$98.19
AFMD
-34.94%
$0.18
MU
-3.20%
$226.65
ALIT
-0.46%
$2.16
USAR
+24.67%
$17.48
ORCL
+3.17%
$214.33
RIG
-0.44%
$4.43
KR
-4.62%
$63.14
MSPR
+15.26%
$0.32
HBAN
+0.35%
$17.10
APLD
+6.06%
$31.14
MSFT
+0.65%
$480.84
VIVK
+11.18%
$0.10
OKLO
+15.59%
$111.65
OWL
+2.55%
$16.06
BTG
+1.33%
$4.56
LPTX
+368.57%
$2.05
PAVS
-7.35%
$0.03
KALA
+4.21%
$0.96
NVDA
+2.11%
$183.38
ASST
-6.99%
$0.97
PLUG
0.00%
$2.23
PMCB
+54.21%
$1.21
INTC
-7.44%
$40.50
ONDS
+3.02%
$9.19
QCLS
+48.17%
$6.92
TNFA
+48.17%
$6.92
KITT
-25.00%
$1.17
IPG
-1.95%
$24.57
RR
+8.76%
$4.59
RGTI
+15.43%
$30.06
TSLA
+1.74%
$454.53
AXDX
-61.36%
$0.03
ACHR
+7.18%
$8.95
IXHL
+7.13%
$0.47
VHAI
+100.00%
$0.00
BYND
-0.80%
$1.24
INHD
+1.01%
$0.13
SOFI
+1.82%
$29.60
NIO
+4.59%
$5.01
BITF
-0.32%
$3.10
AAL
-1.51%
$14.34
QBTS
+14.55%
$28.73
BBD
+1.39%
$3.63
NFLX
-0.71%
$103.22
ADAP
-15.14%
$0.05
DNN
+5.18%
$2.84
VALE
+1.95%
$13.56
BMNR
+7.90%
$36.32
F
+0.38%
$13.14
AMZN
-1.40%
$229.11
AAPL
-1.21%
$280.70
SOND
-23.45%
$0.12
SMR
+13.45%
$22.85
BMNU
+15.34%
$9.32
RMBL
+60.50%
$3.21
IONZ
-25.48%
$3.10
LNW
-3.71%
$86.22
BAC
+0.12%
$54.16
WBD
-0.12%
$24.54
ADD
-25.47%
$0.05
RIVN
+3.02%
$18.06
IREN
+5.66%
$46.45
KVUE
+0.11%
$16.99
PMI
+82.67%
$3.69
IRBT
-10.61%
$3.03
SRM
+53.27%
$10.30
PFE
+0.50%
$25.70
IONQ
+12.55%
$54.76
CLSK
+3.72%
$15.03
TWOH
+9.09%
$0.00
PLTD
-1.04%
$6.66
BTBT
+2.14%
$2.38
HPE
+2.87%
$22.90
MARA
-0.24%
$12.44
T
+0.27%
$25.39
GOOGL
-0.62%
$317.62
GRAB
+0.56%
$5.30
SNAP
+1.30%
$7.76
CIFR
+6.44%
$19.83
META
+3.42%
$661.53
SOUN
+8.65%
$12.80
CRWV
+8.05%
$85.75
PFSA
-4.57%
$0.18
WULF
+4.64%
$15.10
ITUB
+1.89%
$8.07
PLTR
+1.04%
$177.92
QUBT
+12.51%
$13.58
WLGS
-5.57%
$0.04
EOSE
+15.05%
$15.59
BURU
+7.45%
$0.24
VZ
+1.45%
$41.26
MTSR
-0.35%
$70.50
RKLB
+10.39%
$49.37
STAI
+32.35%
$0.30
PLRZ
+104.51%
$14.50
HIMS
+7.95%
$40.02
ASTS
+18.24%
$72.65
AMD
-0.74%
$215.98
WMT
+0.37%
$114.84
MRVL
-2.00%
$98.19
AFMD
-34.94%
$0.18
MU
-3.20%
$226.65
ALIT
-0.46%
$2.16
USAR
+24.67%
$17.48
ORCL
+3.17%
$214.33
RIG
-0.44%
$4.43
KR
-4.62%
$63.14
MSPR
+15.26%
$0.32
HBAN
+0.35%
$17.10
APLD
+6.06%
$31.14
MSFT
+0.65%
$480.84
VIVK
+11.18%
$0.10
OKLO
+15.59%
$111.65
OWL
+2.55%
$16.06
BTG
+1.33%
$4.56
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.